Barclays PLC Raises Holdings in LifeVantage Co. (NASDAQ:LFVN)

Barclays PLC increased its stake in shares of LifeVantage Co. (NASDAQ:LFVN) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,472 shares of the company’s stock after acquiring an additional 1,506 shares during the period. Barclays PLC owned about 0.35% of LifeVantage worth $763,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of LFVN. LPL Financial LLC increased its holdings in shares of LifeVantage by 301.0% during the 4th quarter. LPL Financial LLC now owns 211,039 shares of the company’s stock valued at $3,700,000 after purchasing an additional 158,405 shares in the last quarter. American Century Companies Inc. increased its holdings in LifeVantage by 50.5% in the fourth quarter. American Century Companies Inc. now owns 95,552 shares of the company’s stock valued at $1,675,000 after buying an additional 32,055 shares in the last quarter. O Shaughnessy Asset Management LLC increased its holdings in LifeVantage by 56.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company’s stock valued at $1,640,000 after buying an additional 33,658 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of LifeVantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock worth $1,300,000 after acquiring an additional 22,620 shares in the last quarter. Finally, Ritholtz Wealth Management grew its position in shares of LifeVantage by 65.2% during the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock valued at $830,000 after acquiring an additional 18,682 shares during the period. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Raymond B. Greer sold 8,000 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $20.15, for a total transaction of $161,200.00. Following the completion of the sale, the director now owns 99,288 shares of the company’s stock, valued at $2,000,653.20. This represents a 7.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 20.65% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on LifeVantage in a report on Tuesday, January 14th. They issued a “buy” rating and a $35.00 price target for the company.

LifeVantage Stock Performance

Shares of NASDAQ LFVN opened at $12.00 on Wednesday. The firm has a fifty day moving average of $14.53 and a 200 day moving average of $16.34. The firm has a market cap of $150.61 million, a PE ratio of 21.43 and a beta of 0.41. LifeVantage Co. has a one year low of $5.22 and a one year high of $27.38.

LifeVantage (NASDAQ:LFVN) last released its earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.10. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%. The business had revenue of $58.44 million during the quarter, compared to analysts’ expectations of $60.99 million.

LifeVantage Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be paid a $0.045 dividend. This is a positive change from LifeVantage’s previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.50%. LifeVantage’s payout ratio is currently 28.57%.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.